TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (Cybin or the Firm), a clinical-stage breakthrough neuropsychiatry firm dedicated to revolutionizing psychological healthcare by creating...
TD Cowen has reaffirmed its Purchase score on shares of Insulet (NASDAQ:) Company (NASDAQ: PODD), sustaining a worth goal of $264.00. The endorsement comes...
